Hans Helge Dahlkvist
Linköping university, Sweden
Hans Helge Dahlkvist, After graduate studies at the Faculty of Medicine, University of Linköping, PhD/MD in 1983 and professor of Pharmacology in 1987 at Linköping University. Experience as project manager in drug development at Hoffman LaRoche and Pfizer and course director and lecturer at Linköping and Stockholm University, manager of higher education in medical and natural sciences at Åsö College and responsible for theme days and project manager in educational development nationally and internationally.
My research interest is to describe probable hibernation phenotypes, common to a vast variety of organisms, including humans; with well‐known biochemical pathways to point‐out specific metabolic trails that may relate to different aspects of hibernation. It can be explained as a strong genetic hibernant machinery inherited since the First Cell, modified by specific environmental conditions required for an appropriate adaptation. Hibernation can be seen as a key energetic survival response common in species from different Kingdoms, developed by them, but phenotypically changes, according to their evolutionary complexity level.